Merck Germany to deploy ACD/Labs Percepta Enterprise Server

Merck Germany to deploy ACD/Labs Percepta Enterprise Server

Merck Germany has made a decision to deploy ACD/Labs Percepta Enterprise software at their Research facilities in Germany and North America.

The software platform provides in silico tools for the prediction of Physicochemical, ADME and Tox properties, helping support the medicinal chemists in their planning of syntheses and optimization of new chemical entities.

The main reasons for choosing ACD/Labs Percepta Enterprise were its ease of use and, in particular, its configurability and ability to use existing in-house built algorithms.


ACD/Percepta builds on over a decade of expertise, and industry-leading prediction capabilities, to deliver a flexible project support platform for R&D. This seamless environment includes our full complement of physicochemical and ADME-Tox applications. In addition it offers an enterprise system for sharing chemical data and the ability to easily implement in-house calculation routines and algorithms organization-wide.